Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeated Controlled Human Schistosoma Mansoni Infection
NCT05085470Completed
- Sponsor
- Leiden University Medical Center
- Start
- Oct 2021
- Primary completion
- Jan 2023
- Countries
- 1
01
Overview
Randomised, double-blind trial in schistosomiasis (2 arms), sponsored by Leiden University Medical Center. Primary endpoints: Protective efficacy at week 30 and Safety of (repeated) exposure to male Sm cercariae based on self-reported adverse events at 38 weeks. Started Oct 2021; status: completed.
02
Conditions
schistosomiasis
Beyond the preview
Go deeper on NCT05085470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05085470.